Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed2
Other2

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT05905003Active Not Recruiting
AMP SCZ® Observational Study: PREDICT-DPACC
Clinical High RiskConversionPsychosis+1 more
PrincipalinvestigatorStart date: 2022-06-02
NCT04338152Not ApplicableActive Not Recruiting
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
FamilyProdromal SchizophreniaProdromal Symptoms+2 more
PrincipalinvestigatorStart date: 2021-01-15
NCT00000246Phase 2Completed
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Substance-Related Disorders
Principalinvestigator
NCT00309452Not ApplicableCompleted
Specialized Treatment Early in Psychosis (STEP)
Schizophrenia and Disorders With Psychotic Features
Studychair

Research Network

Collaboration Network

13 collaborators·49 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Martha E Shenton, Ph.D.

Brigham and Women's Hospital/Harvard Medical School

Moderately Similar
1 trials

Shared therapeutic areas:

Clinical High RiskConversionPsychotic Disorders+1 more

Worked with same sponsors:

Brigham and Women's HospitalNational Institute of Mental Health (NIMH)+2 more
Collaborated on 1 trial
Similarity Score44%

Daniel H. Mathalon, Ph.D., M.D.

University of California, San Francisco

Moderately Similar
1 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

Barbara A. Cornblatt, Ph.D., M.B.A.

Hofstra University / Northwell Health

Moderately Similar
1 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

Michelle Friedman-Yakoobian, Ph.D.

Harvard Medical School/Massachusetts Mental Health Center

Moderately Similar
1 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

David J. Miklowitz, Ph.D.

University of California, Los Angeles

Moderately Similar
2 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

Kristin S. Cadenhead, M.D.

University of California, San Diego

Moderately Similar
1 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

Andrea M. Auther, Ph.D.

Zucker Hillside Hospital at Hofstra / Northwell Health

Moderately Similar
1 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

Holly K. Hamilton, Ph.D.

University of California, San Francisco

Moderately Similar
1 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

Barnaby Nelson, Ph.D.

Center for Youth Mental Health at the University of Melbourne/Orygen

Moderately Similar
1 trials

Shared therapeutic areas:

Clinical High RiskConversionPsychotic Disorders+1 more

Worked with same sponsors:

Brigham and Women's HospitalNational Institute of Mental Health (NIMH)+2 more
Collaborated on 1 trial
Similarity Score44%

Jean M. Addington, Ph.D.

University of Calgary

Moderately Similar
1 trials

Shared therapeutic areas:

FamilyProdromal SchizophreniaProdromal Symptoms+1 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of California, Los Angeles
Collaborated on 1 trial
Similarity Score44%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05905003PrincipalInvestigator

AMP SCZ® Observational Study: PREDICT-DPACC

Clinical High RiskConversionPsychosis+1 more
Active Not Recruiting
NCT04338152Not ApplicablePrincipalInvestigator

Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial

FamilyProdromal SchizophreniaProdromal Symptoms+2 more
Active Not Recruiting
NCT00000246Phase 2PrincipalInvestigator

Rapid Benzodiazepine Detoxification Using Flumazenil - 1

Substance-Related Disorders
Completed
NCT00309452Not ApplicableStudyChair

Specialized Treatment Early in Psychosis (STEP)

Schizophrenia and Disorders With Psychotic Features
Completed

All 4 trials loaded